Results 21 to 30 of about 26,203 (316)
New players in the preventive treatment of migraine. [PDF]
, 2015 Migraine is a common, chronic disorder of the brain causing much disability, as well as personal, familial and societal impact. Several oral preventive agents are available in different countries for the prevention of migraine, but none have performed ...
Mitsikostas, Dimos D, Rapoport, Alan M
core +3 more sources
Episodic Acute Migraine Treatment [PDF]
Headache: The Journal of Head and Face Pain, 2014 The ideal migraine medication would provide rapid “one and done” treatment of migraine for all sufferers. Unfortunately, no such intervention is available. While most people respond to triptans or DHE, some will need to combine these with an NSAID, or will choose to use an NSAID alone because of personal preference or for medical reasons.
openaire +2 more sources
Neurology and Therapy, 2023 Introduction Eptinezumab is a humanized IgG1 immunoglobulin monoclonal antibody administered intravenously as a preventative migraine treatment. Previously conducted randomized, double-blind, placebo-controlled trials exhibited significant reductions in ...
Yazan Bader +5 more
doaj +1 more source
Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]
, 2009 There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari +52 more
core +1 more source
Defining the Differences Between Episodic Migraine and Chronic Migraine [PDF]
Current Pain and Headache Reports, 2011 Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities. Population-based studies have shown that those with CM demonstrate higher individual and societal burden because they are significantly more disabled than those with EM and have greater impaired quality of life both ...
Katsarava, Zaza +3 more
openaire +2 more sources
Pain perception and migraine [PDF]
, 2018 Background: It is well-known that both inter-and intra-individual differences exist in the perception of pain; this is especially true in migraine, an elusive pain disorder of the head.
Coppola, Gianluca +6 more
core +1 more source
Episodic and Chronic Migraine in Primary Care [PDF]
Headache: The Journal of Head and Face Pain, 2019 Objective To inform migraine care model development by assessing differences between patients with chronic migraine (CM) and episodic migraine (EM) in the current state of treatment, disability, patient satisfaction, and quality improvement opportunities.
Nathan P. Young +6 more
openalex +4 more sources
Noninvasive vagus nerve stimulation as acute therapy for migraine. The randomized PRESTO study [PDF]
, 2018 Objective: To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, double-blind, randomized, sham-controlled ...
Ambrosini, Anna +12 more
core +2 more sources
Migraine and cluster headache show impaired neurosteroids patterns [PDF]
, 2019 Background: Perturbation of neuronal excitability contributes to migraine. Neurosteroids modulate the activity of γ-aminobutyric acid A and N-methyl-d-aspartate receptors, and might be involved in the pathogenesis of migraine.
Capi, M. +13 more
core +1 more source
Contemporary Clinical Trials Communications, 2020 Introduction: Approximately 15% of the US population experiences migraine, with women afflicted three times as often as men. While medications are often used as first-line treatments, up to 50% of people with migraine pursue complementary and integrative
P.M. Wayne +8 more
doaj +1 more source